CRDL
Cardiol Therapeutics Inc Class ANASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$152.16M
P/E Ratio
—
EPS
$-0.28
Beta
0.42
52W High
$1.71
52W Low
$0.88
50-Day MA
$1.30
200-Day MA
$1.11
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular diseases (CVD). The company is headquartered in Oakville, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 78,760 |
| EBITDA | $-35.55M |
| Operating Margin | 0.00% |
| Return on Equity | -174.00% |
| Return on Assets | -78.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.13 |
| Price-to-Book | 8.71 |
| Price-to-Sales (TTM) | 1014.87 |
| EV/Revenue | 293.71 |
| EV/EBITDA | 0.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $115.27M |
| Float | $94.00M |
| % Insiders | 2.43% |
| % Institutions | 25.68% |
Historical Volatility
HV 10-Day
33.60%
HV 20-Day
37.72%
HV 30-Day
59.48%
HV 60-Day
67.70%
HV Rank
34.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($7.31 target)
2
Strong Buy3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026